The Impact of National Institutes of Health Funding on U.S. Cardiovascular Disease Research
Radmila Lyubarova, Brandon K. Itagaki, Michael W. Itagaki · 2009
Read The Impact of National Institutes of Health Funding on U.S. Cardiovascular Disease Research by Radmila Lyubarova, Brandon K. Itagaki, Michael W. Itagaki (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0006425.txt.
Introduction
Radmila Lyubarova, Brandon Itagaki, and Michael Itagaki examined United States heart research funding in a 2009 PLOS ONE article. At the time, the National Institutes of Health budget had grown as part of an economic stimulus plan. Yet how NIH funding relates to cardiovascular disease research was poorly understood. The authors set out to map that link.
Their study weighs what extra public money is likely to do to the field. Heart disease research depends heavily on grant support, so funding shifts shape what gets studied. The analysis gives policy makers evidence instead of guesses. It also helps research teams plan around the funding climate.
Catalog record
| CREATOR | Radmila Lyubarova, Brandon K. Itagaki, Michael W. Itagaki |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0006425
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
The Impact of National Institutes of Health Funding on U.S. Cardiovascular Disease Research Authors: Radmila Lyubarova, Brandon K. Itagaki, Michael W. Itagaki Published: 2009, PLOS ONE DOI: 10.1371/journal.pone.0006425 ABSTRACT Intense interest surrounds the recent expansion of US National Institutes of Health (NIH) budgets as part of economic stimulus legislation. However, the relationship between NIH funding and cardiovascular disease research is poorly understood, making the likely impact of this policy change unclear. The National Library of Medicine's PubMed database was searched for articles published from 1996 to 2006, originating from U.S. institutions, and containing the phrases “cardiolog,” “cardiovascular,” or “cardiac,” in the first author's department. Research methodology, journal of publication, journal impact factor, and receipt of NIH funding were recorded. Differences in means and trends were tested with t-tests and linear regression, respectively, with P ≤0.05 for significance. Of 117,643 world cardiovascular articles, 36,684 (31.2%) originated from the U.S., of which 10,293 (28.1%) received NIH funding. The NIH funded 40.1% of U.S. basic science articles, 20.3% of overall clinical trials, 18.1% of randomized-controlled, and 12.2% of multicenter clinical trials. NIH-funded and total articles grew significantly (65 articles/year, P<0.001 and 218 articles/year, P<0.001, respectively). The proportion of articles receiving NIH funding was stable, but grew significantly for basic science and clinical trials (0.87%/year, P<0.001 and 0.67%/year, P = 0.029, respectively). NIH-funded articles had greater journal impact factors than non NIH-funded articles (5.76 vs. 3.71, P<0.001). NIH influence on U.S. cardiovascular research expanded in the past decade, during the period of NIH budget doubling. A substantial fraction of research is now directly funded and thus likely sensitive to budget fluctuations, particularly in basic science research. NIH funding predicts greater journal impact. INTRODUCTION In a speech given at the 2006 American Heart Association national meeting, Dr. Elias A. Zerhouni, Director of the National Institutes of Health (NIH), emphasized the tremendous benefit derived from prior government funding of clinical research. Dr. Zerhouni used coronary artery disease as an example, where research has prevented one million early deaths at a cost of supporting the NIH of $3.70 per American per year. Despite these proven benefits, the likelihood of an investigator obtaining NIH research funding dropped by a third from 2003 to 2006 [1] . From 2003 to 2008, NIH budgets stagnated, and even declined in terms of real purchasing power [2] , [3] . Dr. Zerhouni described the situation as a “perfect storm,” and was “deeply troubled” about the impact on investigators, particularly junior scientists beginning a career [4] . In February 2009, the issue of NIH funding again took center stage with the passage of the American Recovery and Reinvestment Act (ARRA), which promised an additional $10.4 billion to be spent by fiscal year 2010, a substantial boost for the $30.3 billion 2009 NIH budget [3] , [5] . Adequate funding is critical for continued advancement in cardiovascular disease research. In 2008, the NIH budget was approximately $29 billion, with about $2.9 billion directed toward the National Heart, Lung, and Blood Institute (NHLBI), the institute most directly involved with cardiovascular research [6] . Despite these well-publicized budgetary figures, the actual impact of the NIH on published cardiovascular research is poorly understood. Money flows from the government to research institutions, but the return on that investment, in terms of the quality and quantity of research publications, is almost entirely unknown. Quantifying the output of U.S. cardiovascular research, both NIH-funded and unfunded, is important. Doing so provides a baseline understanding of the volume and characteristics of cardiovascular research, and also allows trend analysis to determine if research productivity is increasing, decreasing, or stagnant. The relative proportion of NIH-funded to total research is also of importance. A large proportion of NIH-funded papers suggests a heavy dependence on direct NIH support. In this instance, research output may change dramatically in response to changes in grant appropriations. A small proportion suggests that research productivity is less influenced by the NIH. In the current context of a surge in available research funding secondary to the ARRA, this information has important policy implications and could impact decisions on grant appropriations. For overall U.S. biomedical research, the NIH accounts for 24% to 28% of total research funding [7] . Specialty-specific studies examining the role of the NIH in research have been performed in radiology [8] , [9] , emergency medicine [10] , [11] , otolaryngology [12] , and neurology [13] . For cardiovascular disease however, the publication impact of NIH funding is unknown. The purpose of this study was to determine the overall volume of world and U.S. cardiovascular research articles, and the component of U.S. cardiovascular articles that did and did not receive NIH funding during the eleven years from 1996 to 2006. NIH funding levels were examined overall and by research methodology to determine which methodologies were most likely to receive funding. Trends were analyzed to determine if funding impact changed over time. The average journal impact factor was examined to determine if article methodology or receipt of NIH funding was associated with the likely scientific impact of the article. Finally, the contributions of individual NIH institutes were examined to determine which ones had budgets and agendas that were most supportive of cardiovascular research. These results provide an overview of the NIH funding landscape in cardiovascular disease research and provide important information for policymakers, research leaders, and clinical investigators who are involved with research grants, and for practicing clinicians interested in continued benefits provided by research. METHODS This study is a retrospective observational study of publicly available data, and was exempted from Institutional Review Board approval. Data collection was performed by MWI, and analysis and interpretation was performed by MWI, RL, and BKI. The data were obtained from PubMed, a freely available database of biomedical citations and abstracts hosted by the National Library of Medicine. The largest component of PubMed is MEDLINE, a database that contains information from more than 5,200 biomedical journals published in more than 80 countries, and in 37 languages [14] , [15] . PubMed contains over 18.8 million citations [16] . DATA SELECTION All articles published during the 11-year period from January 1, 1996 to December 31, 2006 that were indexed in PubMed as of June 20, 2007 and contained the words “cardiac,” “cardiovascular,” and “cardiolog” in the first author affiliation field were captured. The author affiliation field is a PubMed defined field that contains the first author's department, institution, and country. This method allowed capture of citations published by departments of cardiology and related specialties, including surgical, pediatric, and basic science disciplines. In instances where an author was not from a cardiovascular related department but worked within a larger institution dedicated to cardiovascular research, the paper was included. Papers from veterinary medicine departments were specifically excluded as they typically deal with research unrelated to humans. The selection was thus conservative in nature, tending to exclude some legitimate articles where the first author is from an unrelated department in order to ensure that the included articles had the highest chance of being truly cardiovascular in nature. The goal of the chosen keyword selection algorithm was thus not to capture all cardiovascular articles, but rather to capture a large subset with maximum accuracy. The matching citation data were